Enhanced expression of mineralocorticoid receptors in the heart after the myocardial infarct in rats

Journal of Physiology and Pharmacology

Volumn 58, Issue 4, 2007, Pages 745-755

  Milik, E ^a   Szczepańska Sadowska, Ewa ^a   Maslinski W ^a   Cudnoch Jedrzejewska A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cardiac hypertrophy; Heart failure; Heart infarct; MR mRNA

Indexed keywords

MINERALOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; KIDNEY; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER;

EID: 38149020049     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116: 263-272.
2. Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 2005; 14: 235-241.
3. Bonvalet JP, Alfaidy N, Farman N, Lombes M. Aldosterone: intracellular receptors in human heart. Eur Heart J 1995; 16 (Suppl N): 92-97.
4. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Origin of aldosterone in the rat heart. Endocrinology 2004; 145: 4796-4802.
5. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 2005; 288: E342-E346.
6. Hansson AC, Fuxe K. Biphasic autoregulation of mineralocorticoid receptor mRNA in the medial septal nucleus by aldosterone. Neuroendocrinology 2002; 75: 358-366.
7. Jackiewicz E, Szczepańska-Sadowska E, Maśliński W. Expression of mineralocorticoid receptors mRNA in the brain, heart and kidney of Sprague Dawley rats with renovascular hypertension. Brain Res Bull 2005; 65: 23-29.
8. Yu L, Romero DG, Gomez-Sanchez CE, Gomez-Sanchez EP. Steroidogenic enzyme gene expression in the human brain. Moll Cell Endocrinol 2002; 190: 9-17.
9. Konishi A, Tazawa C, Miki Y et al. The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat. J Steroid Biochem Mol Biol 2003; 85: 439-442.
10. Gomez-Sanchez CE, Gomez-Sanchez EP. Role of central mineralocorticoid receptors in cardiovascular disease. Curr Hypertens Rep 2001; 3: 263-269.
11. Lal A, Veinot JP, Leenen FH. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 2004; 64: 437-447.
12. Rossi G, Boscaro M, Ronconi V, Funder JW. Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab 2005; 16: 104-107.
13. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann NY Sci 2002; 970: 89-100.
14. Yoshida M, Ma J, Tomita T. et al. Mineralocoricoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure. Congest Heart Failure 2005; 11: 12-16.
15. Abraham WT, Schrier RW. Renal and water handling in congestive heart failure. In: JD Hosenpud, BD Greenberg, eds Congestive Heart Failure, Philadelphia, Baltimore, New York, London, Lippincott Williams and Wilkins, 2000 pp. 253-266.
16. Akatsu T, Nakamura M, Satok M, Hiramori K. Increased mRNA expression of tumor necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. Clin Sci 2003; 105: 39-44.
17. Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension Curr Opin Cardiol 2006; 21: 295-304.
18. Leenen FHH, Yuan B, Huang BS. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 1999; 277: H1786-H1792.
19. Rouleau JL, Moye LA, de Champlain J et al. Activation of neurohumoral systems following acute myocardial infarction. Am J Cardiol 1991; 68: 80D-86D.
20. th International Congress of Polish Cardiac Society. Katowice, Poland 22-24 09, 2005. Polish Heart J 2005; 63: P501.
21. Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960; 11: 398-407.
22. Dobruch J, Cudnoch-Jȩdrzejewska A, Szczepanska-Sadowska E. Stress-enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction. Stress 2005; 8: 273-284.
23. Milik E, Szczepanska-Sadowska E, Cudnoch-Jȩdrzejewska A, Dobruch J, Morton M, Koperski Ł. Upregulation of angiotensin AT1a receptors mRNA in the heart and renal medulla after myocardial infarction in rats. J Physiol Pharmacol 2006; 57: 375-388.
24. Bouaboula M, Legoux P, Pessegue B et al. Standarization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 1992; 25: 21830-21838.
25. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120-5127.
26. Fiebeler A, Luft FC. The mineralocorticoid receptor and oxidative stress. Heart Failure Rev 2005; 10: 47-52.
27. Fiebeler A, Muller DN, Shagdarsuren E, Luft FC. Aldosterone, mineralocorticoid receptors, and vascular inflammation. Curr Opin Nephrol Hypertens 2007; 16: 134-142.
28. Delacyre C, Silvestre JS, Garnier A et al. Cardiac aldosterone production and ventricular remodeling. Kidney Int 2000; 57: 1346-1351.
29. Kliche K, Kuhn M, Hillebrand U et al. Direct aldosterone action on mouse cardiomyocytes detected with atomic force microscopy. Cell Physiol Biochem 2006; 18: 265-274.
30. Okoshi MP, Yan X, Okoshi K et al. Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 2004; 10: 511-518.
31. Perrier E, Kerfant BG, Lalevee N et al. Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation 2004; 110: 776-783.
32. Beygui F, Collet JP, Benolliel JJ et al. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation 2006; 114: 2604-2610.
33. Bauersachs J, Ertl G. Aldosterone receptor blockade after acute myocardial infarction with heart failure. Med Klin (Munich) 2006; 15: 101: 458-466.
34. Delyani JA, Robinson EL, Rudolph AE. Effect of a selective aldosterone receptor antagonist in myocardial infarction. Am J Physiol Heart Circ Physiol 2001; 281: H647-54.
35. Cudnoch-Jȩdrzejewska A, Dobruch J, Puchalska L, Szczepańska-Sadowska E. Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state. Regul Pept 2007; 142: 86-94.
36. Cudnoch-Jȩdrzejewska A, Szczepańska-Sadowska E, Dobruch J et al. Fluid consumption, electrolyte excretion and heart remodeling in rats with myocardial infarct maintained on regular and high sodium intake. J Physiol Pharmacol 2005; 56: 599-610.
37. Ono K, Matsumori A, Shioi T et al. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998; 98: 149-156.
38. Sano M, Fukuda K, Kodama H et al. Interleukin-6 family of cytokines mediates angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 2000; 275: 29717-29723.